BRINP3 is primarily involved in neural development and has a noted pharmacokinetic interaction with uric acid, possibly influencing metabolic pathways that affect uric acid levels. This interaction is significant due to its potential influence on conditions like gout or kidney diseases, although the connection is not yet well established in the literature.